Technical Analysis for CTXR - Citius Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.911 -5.97% -0.06
CTXR closed down 5.97 percent on Friday, September 13, 2019, on 2.55 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CTXR trend table...

Date Alert Name Type % Chg
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish -5.97%
MACD Bearish Signal Line Cross Bearish -5.97%
Volume Surge Other -5.97%
Stochastic Reached Oversold Weakness -5.97%

Older signals for CTXR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care, and prescription products. Its product candidates include Mino-Lok and Hydrocortisone-Lidocaine Cream. The Company's Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. The Company's Hydrocortisone-Lidocaine topical formulation provides anti-inflammation and anesthetic relief to persons suffering from hemorrhoids. Its Mino-Lok product for the treatment of catheter related bloodstream infections has completed Phase IIb and is entering Phase III trials. It is reformulating Hydrocortisone-Lidocaine product and will be entering Phase IIb trials in 2017. As of September 30, 2016, the Company had not generate any revenues.
Medicine Medical Specialties Pharmaceutical Drugs Catheter Cancer Care Care Products Prescription Products Acetamides Lidocaine
Is CTXR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.52
52 Week Low 0.8582
Average Volume 94,626
200-Day Moving Average 1.1348
50-Day Moving Average 1.1017
20-Day Moving Average 1.0803
10-Day Moving Average 1.093
Average True Range 0.0849
ADX 21.9
+DI 28.2284
-DI 28.3039
Chandelier Exit (Long, 3 ATRs ) 1.0953
Chandelier Exit (Short, 3 ATRs ) 1.1657
Upper Bollinger Band 1.2341
Lower Bollinger Band 0.9265
Percent B (%b) -0.05
BandWidth 28.473572
MACD Line -0.0194
MACD Signal Line -0.004
MACD Histogram -0.0154
Fundamentals Value
Market Cap 7.52 Million
Num Shares 8.25 Million
EPS -1.98
Price-to-Earnings (P/E) Ratio -0.46
Price-to-Sales 0.00
Price-to-Book 1.16
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.04
Resistance 3 (R3) 1.06 1.03 1.02
Resistance 2 (R2) 1.03 1.00 1.02 1.01
Resistance 1 (R1) 0.97 0.97 0.96 0.96 1.01
Pivot Point 0.94 0.94 0.93 0.93 0.94
Support 1 (S1) 0.88 0.91 0.87 0.87 0.81
Support 2 (S2) 0.85 0.89 0.84 0.81
Support 3 (S3) 0.79 0.85 0.80
Support 4 (S4) 0.78